🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of acetaminophen, claiming the firms hid safety concerns that the pain reliever posed to pediatric cognitive development.

The lawsuit follows thirty days after Donald Trump advocated an unproven link between consuming Tylenol - referred to as paracetamol - during pregnancy and autism spectrum disorder in offspring.

The attorney general is filing suit against Johnson & Johnson, which formerly manufactured the drug, the sole analgesic recommended for women during pregnancy, and Kenvue, which now manufacturers it.

In a statement, he claimed they "deceived the public by gaining financially from suffering and promoting medication regardless of the potential hazards."

Kenvue states there is no credible evidence connecting Tylenol to autism.

"These corporations deceived for years, deliberately risking numerous people to boost earnings," Paxton, a Republican, stated.

The company commented that it was "deeply concerned by the spread of false claims on the security of paracetamol and the possible consequences that could have on the welfare of American women and children."

On its official site, the company also mentioned it had "continuously evaluated the relevant science and there is insufficient valid information that demonstrates a proven link between taking acetaminophen and autism spectrum disorder."

Organizations acting on behalf of physicians and healthcare providers concur.

ACOG has said acetaminophen - the primary component in Tylenol - is a restricted selection for pregnant women to address discomfort and fever, which can present major wellness concerns if not addressed.

"In over twenty years of studies on the utilization of paracetamol in pregnancy, not a single reputable study has conclusively proven that the use of paracetamol in any period of gestation causes neurological conditions in offspring," the association said.

This legal action cites latest statements from the former administration in claiming the drug is potentially dangerous.

Last month, Trump generated worry from health experts when he advised women during pregnancy to "struggle intensely" not to consume acetaminophen when ill.

The FDA then released a statement that doctors should contemplate reducing the consumption of acetaminophen, while also stating that "a proven link" between the drug and autism in children has not been established.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had pledged in April to conduct "a massive testing and research effort" that would establish the origin of autism in a limited time.

But specialists advised that finding a unique factor of autism spectrum disorder - considered by experts to be the outcome of a intricate combination of genetic and external influences - would prove challenging.

Autism is a form of enduring cognitive variation and disability that impacts how individuals encounter and interact with the environment, and is recognized using medical professional evaluations.

In his court filing, Paxton - aligned with the former president who is running for US Senate - claims Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism spectrum disorder.

This legal action attempts to require the firms "remove any commercial messaging" that asserts Tylenol is secure for expectant mothers.

This legal action parallels the concerns of a group of mothers and fathers of minors with autism and ADHD who sued the makers of acetaminophen in two years ago.

The court dismissed the lawsuit, saying studies from the family's specialists was inconclusive.